Final results from M72 AS01E TB Vaccine Trial
The final results from the M72AS01E TB vaccine study have been published in the New England Journal of Medicine. The vaccine demonstrated a 50% efficacy rate in reducing the incidence of lung TB disease in HIV-negative adults, already infected with...
Social Reponsiveness
Established in 2001, the South African Tuberculosis Vaccine Initiative (SATVI) was presented with the University of Cape Town’s (UCT) 2018 Social Responsiveness Award at the Faculty of Health Sciences graduation ceremony on Saturday, 13 April 2019
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...


Monday, 27 January 2020
SATVI researcher Dr Luabeya awarded ‘C’ rating from the South African National Research Foundation.

Dr Angelique Luabeya has been awarded "C" rating from the National Research Foundation.

Publication Date:
Wed, 13 Nov 2019 - 15:45
4 November 2019 SATVI Senior Research officer Elisa Nemes promoted to Associate Professor

The interim Dean of the UCT Faculty of Health Sciences has just announced that SATVI Senior Research Officer, Elisa Nemes has been promoted to Associate Professor. 

Publication Date:
Mon, 04 Nov 2019 - 15:30
30 October 2019 Press Conference 30 October 2019 Press Conference: Final results M72/AS01E candidate vaccine

Press Conference: Towards a TB Vaccine, Union World Conference, 29 October 2019:  Watch press conference where the final results M72/AS01E candidate vaccine against tuberculosis (TB)  were announced at the Union Conference on Lung Health, India.

Publication Date:
Wed, 30 Oct 2019 - 13:45
TB Science Conference, 2019: Final results from M72/AS01E candidate vaccine announced

Results from the MM72/AS01E  TB vaccine study have been presented at the Union Conference on Lung Health, India.

Publication Date:
Tue, 29 Oct 2019 - 17:00